NDC 0009-3375-01 - Cleocin Phosphate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0009-3375
- Requested NDC
- 0009-3375-01
- Package NDCs from labels
- 0009-3375-01, 0009-3375-02
- Manufacturer
- Pharmacia & Upjohn Company LLC
- Effective date
- 2026-07-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cleocin Phosphate - Pharmacia & Upjohn Company LLC | Pharmacia & Upjohn Company LLC | 2026-07-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0009-3375-01 | Cleocin Phosphate | 50 mL in 1 BAG | INJECTION, SOLUTION | 50 | 59 | |
| 0009-3375-02 | Cleocin Phosphate | 2 in 1 PACKAGE | INJECTION, SOLUTION | 2 | 59 | |
| 0009-3375-02 | Cleocin Phosphate | 12 in 1 CARTON | INJECTION, SOLUTION | 12 | 59 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0009-3375 | CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) INJECTION, SOLUTION CLEOCIN PHOSPHATE (0009-6582) (STANDALONE) (CLINDAMYCIN PHOSPHATE) INJECTION, SOLUTION [PHARMACIA & UPJOHN COMPANY LLC] | 55 | Legacy NDC, 3 package rows | 20250406_05a75685-0af5-407c-ac57-e380c882b49d.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0009-3375-02 | ML - Milliliter | 0009-3375 | 099fea4b-feb8-48fb-8afd-627791b1ca6c | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CLINIMIX E | LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, DIBASIC POTASSIUM PHOSPHATE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, DEXTROSE | Baxter Healthcare Company | 8469d6fb-d6ef-476f-8cc3-0905192de0a8 | 2021-04-13 | Warnings, Adverse reactions | IY9XDZ35W2 |
| CLINIMIX | LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, DEXTROSE | Baxter Healthcare Corporation | dccff103-8695-400c-a15d-cc2fd078760a | 2021-04-13 | Warnings, Adverse reactions | IY9XDZ35W2 |
| Acanya | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Bausch Health US, LLC | 3dcd2c96-72b1-4a9f-b65c-08198d63b7df | 2020-09-30 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate and Benzoyl Peroxide | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Oceanside Pharmaceuticals | edae294f-cc8b-4f94-8d90-4c764fda307b | 2020-09-30 | Warnings, Adverse reactions | EH6D7113I8 |
| POTASSIUM CHLORIDE IN DEXTROSE | DEXTROSE AND POTASSIUM CHLORIDE | B. Braun Medical Inc. | e5bbb3e1-ab50-4ec7-a2b4-ce4091712e23 | 2020-07-31 | Warnings, Adverse reactions | IY9XDZ35W2 |
| Clindamycin Phosphate 1.2% and Tretinoin 0.025% | CLINDAMYCIN PHOSPHATE AND TRETINOIN | Oceanside Pharmaceuticals | 63b2e85d-8fe5-4f18-9e85-8492c49a7520 | 2020-04-01 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindagel | CLINDAMYCIN | Bausch Health US, LLC | f7b4e985-719a-4547-b624-94612d520991 | 2020-01-01 | Warnings, Adverse reactions | EH6D7113I8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.